Day Pitney remains committed to providing quality legal counsel, while protecting our clients and employees, and transforming our communities into more just, equal and equitable spaces. For more information, please visit our COVID-19 Resource Center | Racial Justice and Equity Task Force.
Erin Magennis Healy combines industry knowledge with technical experience to provide comprehensive legal representation to clients operating in the healthcare and life sciences industries, as well as strategic advice to private equity firms and other investors seeking to evaluate risks in a complicated regulatory landscape. Erin is well-versed on federal and state compliance matters, including fraud and abuse laws, anti-kickback and self-referral laws, FDA regulations and limitations on the use and disclosure of personal information. In addition to helping clients develop and implement comprehensive compliance and training programs, Erin serves as deal counsel on a wide range of mission-critical transactions including mergers and acquisitions, licensing agreements, research agreements, manufacturing, supply and distribution agreements, and other strategic commercial arrangements. She also supports clients on day-to-day legal matters, offering creative and practical advice to help clients achieve commercial goals.
Erin previously managed clinical trials at top academic medical centers in New York City and contributed to several published, peer-reviewed articles on surgical and clinical outcomes, affording her substantial experience developing clinical trial agreements and a strong background in federal and institutional research regulations.
Selected to the list of New Jersey Super Lawyers Rising Stars (Thomson Reuters), Health Care, 2018-2019
No aspect of these advertisements has been approved by the highest court of any state. See Awards Methodology.
